Literature DB >> 29731404

Tumor Resection Margin Definitions in Breast-Conserving Surgery: Systematic Review and Meta-analysis of the Current Literature.

Susan G Brouwer de Koning1, Marie-Jeanne T F D Vrancken Peeters2, Katarzyna Jóźwiak3, Patrick A Bhairosing4, Theo J M Ruers5.   

Abstract

Worldwide, various guidelines recommend what constitutes an adequate margin of excision for invasive breast cancer or for ductal carcinoma-in-situ (DCIS). We evaluated the use of different tumor resection margin guidelines and investigated their impact on positive margin rates (PMR) and reoperation rates (RR). Thirteen guidelines reporting on the extent of a positive margin were reviewed along with 31 studies, published between 2011 and 2016, reporting on a well-defined PMR. Studies were categorized according to the margin definition. Pooled PMR and RR were determined with random-effect models. For invasive breast cancer, most guidelines recommend a positive margin of tumor on ink. However, definitions of reported positive margins in the clinic vary from more than focally positive to the presence of tumor cells within 3 to 5 mm from the resection surface. Within the studies analyzed (59,979 patients), pooled PMRs for invasive breast cancer ranged from 9% to 36% and pooled RRs from 77% to 99%. For DCIS, guidelines vary between no DCIS on the resection surface to DCIS cells found within a distance of 2 mm from the resection edge. Pooled PMRs for DCIS varied from 4% to 23% (840 patients). Given the differences in tumor margin definition between countries worldwide, quality control data expressed as PMR or RR should be interpreted with caution. Furthermore, the overall definition for positive resection margins for both invasive disease and DCIS seems to have become more liberal.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ductal carcinoma in situ; Guidelines; Invasive breast cancer; Positive resection margin rate; Reoperation rate

Mesh:

Year:  2018        PMID: 29731404     DOI: 10.1016/j.clbc.2018.04.004

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  12 in total

1.  The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.

Authors:  Francesca Tamburelli; Riccardo Ponzone
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  The Margins' Challenge: Risk Factors of Residual Disease After Breast Conserving Surgery in Early-stage Breast Cancer.

Authors:  Piero Fregatti; Marco Gipponi; Giulia Atzori; Raffaele DE Rosa; Raquel Diaz; Chiara Cornacchia; Marco Sparavigna; Alessandro Garlaschi; Liliana Belgioia; Alessandra Fozza; Francesca Pitto; Luca Boni; Eva Blondeaux; Francesca Depaoli; Federica Murelli; Simonetta Franchelli; Gabriele Zoppoli; Matteo Lambertini; Daniele Friedman
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Does Mammotome biopsy affect surgery option and margin status of breast conserving surgery in breast cancer?

Authors:  Yanan Kong; Ning Lyu; Jianwei Wang; Yan Wang; Ya Sun; Zeming Xie; Peng Liu
Journal:  Gland Surg       Date:  2021-08

4.  Discriminating healthy from tumor tissue in breast lumpectomy specimens using deep learning-based hyperspectral imaging.

Authors:  Lynn-Jade S Jong; Naomi de Kruif; Freija Geldof; Dinusha Veluponnar; Joyce Sanders; Marie-Jeanne T F D Vrancken Peeters; Frederieke van Duijnhoven; Henricus J C M Sterenborg; Behdad Dashtbozorg; Theo J M Ruers
Journal:  Biomed Opt Express       Date:  2022-04-04       Impact factor: 3.562

Review 5.  Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.

Authors:  Daan G J Linders; Okker D Bijlstra; Laura C Fallert; Denise E Hilling; Ethan Walker; Brian Straight; Taryn L March; A Rob P M Valentijn; Martin Pool; Jacobus Burggraaf; James P Basilion; Alexander L Vahrmeijer; Peter J K Kuppen
Journal:  Mol Imaging Biol       Date:  2022-08-24       Impact factor: 3.484

6.  Nonlinear multispectral imaging for tumor delineation.

Authors:  Elena Beletkaia; Behdad Dashtbozorg; Rubin G Jansen; Theo J M Ruers; Herman L Offerhaus
Journal:  J Biomed Opt       Date:  2020-09       Impact factor: 3.170

7.  Clinically relevant dual probe difference specimen imaging (DDSI) protocol for freshly resected breast cancer specimen staining.

Authors:  Broderick J House; Marcus J Kwon; Jasmin M Schaefer; Connor W Barth; Allison Solanki; Scott C Davis; Summer L Gibbs
Journal:  BMC Cancer       Date:  2021-04-21       Impact factor: 4.430

8.  MRI-Derived Tumour-to-Breast Volume Is Associated with the Extent of Breast Surgery.

Authors:  Andrea Cozzi; Simone Schiaffino; Gianmarco Della Pepa; Serena Carriero; Veronica Magni; Diana Spinelli; Luca A Carbonaro; Francesco Sardanelli
Journal:  Diagnostics (Basel)       Date:  2021-01-30

9.  Can novel technologies improve breast conserving surgery?

Authors:  Brian W Pogue
Journal:  Breast Cancer Res       Date:  2018-08-03       Impact factor: 6.466

10.  AND-gate contrast agents for enhanced fluorescence-guided surgery.

Authors:  John C Widen; Martina Tholen; Joshua J Yim; Alexander Antaris; Kerriann M Casey; Stephan Rogalla; Alwin Klaassen; Jonathan Sorger; Matthew Bogyo
Journal:  Nat Biomed Eng       Date:  2020-09-28       Impact factor: 25.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.